The Cutting Edge of Medical Technology Content, Community & Collaboration
Time: March 23, 2020 from 1pm to 2:30pm
Location: Online Event
Street: Online Event ,Compliance Key,364 E Main Street, Suite 1009
City/Town: Middletown
Website or Map: https://www.compliancekey.us/…
Phone: 7172088666
Event Type: webinar
Organized By: Compliance Key
Latest Activity: Mar 16, 2020
Topic : 21 CFR Part 11 Guidance on Electronic Records and Electronic Signatures for Computer Systems Regulated by FDA
Register: https://www.compliancekey.us/webinarDetails?industryId=3&webinarid=1575&speakerid=60&source=MTN_LN
Discount Coupon : Use this Coupon (NEW2COMPLIANCE) and get (10% Off) On New Signup
Overview
This webinar will help you understand in detail the application of FDA's 21 CFR Part 11 guidance on electronic records/electronic signatures (ER/ES) for computer systems subject to FDA regulations. This is critical in order to develop the appropriate validation strategy and achieve the thoroughness required to prove that a system does what it purports to do. It also ensures that a system is maintained in a validated state throughout its entire life cycle, from conception through retirement.
Areas Covered in the Session :
Speaker Profile :
Carolyn Troiano is Keynote Spe aker at ComplianceKey.She has more than 30 years of experience during which she worked directly, or as a consultant, for many top-tier pharmaceutical, medical device and biological companies in the US and Europe. She was responsible for computer system validation compliance activities across all GxP functions at a major pharmaceutical company. She developed computer system validation programs and strategies and was an industry reviewer for 21 CFR Part 11, the FDA's electronic record/electronic signature (ER/ES) regulation.
Contact Info :
Compliance Key
Email :support@compliancekey.us
Phone : +1 717-208-8666
© 2024 Created by CC-Conrad Clyburn-MedForeSight. Powered by
RSVP for 21 CFR Part 11 Guidance on Electronic Records and Electronic Signatures for Computer Systems Regulated by FDA to add comments!
Join MedTech I.Q.